DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
Arnaud Duchon(Centre National de la Recherche Scientifique), Yann Hérault(Centre National de la Recherche Scientifique)
Cited by 180
Related Papers
A resource of targeted mutant mouse lines for 5,061 genes
|Nature Genetics|2021|114
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation
|Acta Neuropathologica|2019|76
Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome
|Genes|2021|75